Before matching, 265 patients received pRBC transfusion during the first 24 hours of their hospital stays; they tended to have a higher in-hospital mortality rate, lower Hb levels, lower mean arterial pressures, and higher likelihood of malignancy, chronic kidney disease and hematologic organ dysfunction while presenting at the ED. This evidence concerns the gene GSTM1 and chronic kidney disease.